GENE ONLINE|News &
Opinion
Blog

Tumor
Shutting Down Backup Genes Could Provide Key to Targeted Cancer Therapies
2022-10-07
Cowpea Mosaic Virus Sheds Light on Cancer Therapy
2022-05-11
Ultrasound Transducer for Combined Histotripsy Breaks Down Cancer Tumors
2022-04-27
Novel 3D Microscopy Captures Real-Time Histological Images of Internal Organs
2022-04-04
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
The Maturation of Blood-Based Diagnostics to Nip Cancers in the Bud: An Interview with Dr. Jimmy Lin
2021-06-02
ASGCT21 Highlights: Present Trends and Future Directions of Gene and Cell Therapies in Immuno-Oncology
2021-05-14
Interferon-γ Pathway Helps Cancer Cells Evade Immune Therapy
2021-02-28
Spotlight: Cholesterol Reducing Drugs Could Potentially Augment Cancer Immunotherapy
2020-11-22
A New Imaging Tool Predicts Response of Cancer Patients to Immune Checkpoint Inhibition Therapy
2020-08-30
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
2020-08-19
AstraZeneca, Daiichi Sankyo Ink $6 Billion Deal for Lung and Breast Cancer Treatments
2020-07-28
FDA Approves Crysvita for Victims of Tumor-Induced Osteomalacia
2020-07-03
Early Kidney Cancer Detection Made Possible with a Simple Blood Test
2020-06-25
R&D
ASCO 2020: Results from the INFORM Registry, A Step Towards Personalized Therapy in Pediatric Cancer
2020-05-29
1 2
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top